专利检索 ap:("EVANGELOS KARAVAS" OR "EFTHIMIOS KOUTRIS" OR "DIMITRIOS BIKIARIS" OR "SOTIRIA CHATIDOU" OR "AMALIA DIAKIDOU" OR "PANAGIOTIS BARMPALEXIS" OR "LOUIZA KONSTANTI" OR "KATERINA MINIOTI") AND inv:"LOUIZA KONSTANTI" 第 1 页

1.

发明申请
STABLE INJECTABLE PHARMACEUTICAL COMPOSITION OF NEUROKININ 1 RECEPTOR ANTAGONIST AND PROCESS FOR PREPARATION THEREOF 审中-公开

公开(公告)号：US20200237920A1

公开(公告)日：2020-07-30

申请号：US16851779

申请日：2020-04-17

申请人： EVANGELOS KARAVAS , EFTHIMIOS KOUTRIS , DIMITRIOS BIKIARIS , SOTIRIA CHATIDOU , AMALIA DIAKIDOU , PANAGIOTIS BARMPALEXIS , LOUIZA KONSTANTI , KATERINA MINIOTI

发明人： EVANGELOS KARAVAS , EFTHIMIOS KOUTRIS , DIMITRIOS BIKIARIS , SOTIRIA CHATIDOU , AMALIA DIAKIDOU , PANAGIOTIS BARMPALEXIS , LOUIZA KONSTANTI , KATERINA MINIOTI

IPC分类号： A61K47/38 , A61K31/5377 , A61K9/00 , A61K9/70 , A61K31/675 , A61K47/14 , A61K47/34 , A61K47/44 , A61K47/46

摘要： The present invention relates to a controlled release sterile injectable formulation in the form of solution, suspension or sol-gel formulation for intramuscular or subcutaneous administration comprising a therapeutically effective amount of a neurokinin 1 receptor antagonist, in particular Aprepitant or Fosaprepitant or pharmaceutical acceptable salt, derivative or metabolite thereof. It also relates to a process for developing such formulations.